# FDA Inspection 797357 - Octapharma Plasma, Inc. - August 23, 2012

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e124831c-3e3d-40b9-9208-e28c7f3af9ca
Source feed: FDA_Inspections

> FDA Inspection 797357 for Octapharma Plasma, Inc. on August 23, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 797357
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2012-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1082634 - 2019-02-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/c7e67d7f-961c-4f4d-b907-2728fd30ca14)
- [FDA Inspection 963334 - 2016-03-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/73fefadf-9780-41e0-836c-531804b649ac)
- [FDA Inspection 881205 - 2014-04-25](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/b4c08c36-61b3-482d-bdd0-36404991d7cf)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/cebf65cb-38a4-4ab2-afea-52544035626c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d